These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8549345)

  • 21. Evaluation of clinical efficacy of antimicrobials in complicated urinary tract infections. Comparison of Japanese criteria with IDSA guidelines. Infectious Diseases Society of America.
    Kawada Y; Lee SE; Chen C; Limson BM; Chan P; Kongkanand A; Wudhikarn S; Tung KH; Rahardjo P; Saito I
    Drugs; 1995; 49 Suppl 2():362-4. PubMed ID: 8549363
    [No Abstract]   [Full Text] [Related]  

  • 22. Ofloxacin in urinary tract infections.
    Kromann-Andersen B; Krøyer Nielsen K
    Scand J Infect Dis Suppl; 1990; 68():35-40. PubMed ID: 2218420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections.
    Sawae Y; Ninomiya K; Takaki K; Shimono N; Misumi H; Okada K
    Drugs; 1995; 49 Suppl 2():430-2. PubMed ID: 8549390
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-dose treatment of female acute uncomplicated cystitis.
    Kumamoto Y
    Infection; 1992; 20 Suppl 3():S173-4. PubMed ID: 1337061
    [No Abstract]   [Full Text] [Related]  

  • 25. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
    McMullin CM; Brown NM; Brown IM; Tomson CR; White LO; Reeves DS; MacGown AP
    J Antimicrob Chemother; 1997 Jun; 39(6):829-31. PubMed ID: 9222057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.
    Chow AT; Fowler C; Williams RR; Morgan N; Kaminski S; Natarajan J
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion of ofloxacin into saliva in patients with respiratory tract infection.
    Takagi K; Hasegawa T; Yamaki K; Suzuki K; Nabeshima T
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):46-50. PubMed ID: 1551745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Column-switching high-performance liquid chromatography of ofloxacin in human saliva and correlation of ofloxacin level in saliva and serum.
    Ohkubo T; Suno M; Kudo M; Uno T; Sugawara K
    Ther Drug Monit; 1996 Oct; 18(5):598-603. PubMed ID: 8885126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical efficacy of levofloxacin in elderly patients with respiratory tract infections.
    Sato A; Ogawa H; Iwata M; Ono T; Yasuda K; Nagayama M; Shirai T; Shirai M; Ida M; Suda T
    Drugs; 1995; 49 Suppl 2():428-9. PubMed ID: 8549388
    [No Abstract]   [Full Text] [Related]  

  • 34. Ofloxacin population pharmacokinetics in patients with tuberculosis.
    Stambaugh JJ; Berning SE; Bulpitt AE; Hollender ES; Narita M; Ashkin D; Peloquin CA
    Int J Tuberc Lung Dis; 2002 Jun; 6(6):503-9. PubMed ID: 12068983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ten-year experience with the use of ofloxacin in reconstructive surgery].
    Bogomolova NS; Bol'shakov LV; Vinogradova LN; Sorokina VI; Oreshkina TD
    Antibiot Khimioter; 1996; 41(9):68-72. PubMed ID: 9005791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure].
    Tsubakihara Y; Hayashi T; Shoji T; Kitamura E; Okada N; Nakanishi I
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):246-9. PubMed ID: 8196221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of urinary infections after kidney transplant with ofloxacin (RG 191). Preliminary results].
    Prati GF; Recchia G; Dean P; Galvani E; Muolo A; Fostini R; Ancona G
    G Ital Chemioter; 1985; 32(2):501-4. PubMed ID: 3914437
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 2 oral ofloxacin regimens for the treatment of bacteriuria in elderly subjects.
    Zorbas P; Giamarellou H; Staszewska-Pistoni M; Petrikkos G; Grammatikou M; Dontas AJ
    Drugs; 1995; 49 Suppl 2():384-6. PubMed ID: 8549370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.